In support of the Singapore government's effort in dealing with the evolving C0VID-19 situation, Manulife Singapore has enhanced its protection coverage for all customers.

A S$1 million COVID-19 support fund has been set up to provide additional protection coverage to customers in Singapore, at no added cost. Effective from 17 February 2020 until 1 June 2020, Manulife Singapore will provide the following protection coverage:

(1)  New: Diagnosis Benefit(s)

Customers who are diagnosed with COVID-19 in Singapore will receive a one-time immediate cash benefit of S$1,500. If the customer with a confirmed diagnosis of C0VID-19 is hospitalized for 5 days or more, an additional cash benefit of S$2,000 (ie a total of S$3,500) would be payable.

(2)  Additional Death Benefit

In the unfortunate event that death occurs as a result of the diagnosis of COVID-19, an additional lump sum of S$30,000 will be paid out on top of the death benefit from the customer's existing policy.

Manulife Singapore remains committed to supporting the community amid the COVID-19 outbreak. It recently donated S$100,000 to The Courage Fund in support of those at the forefront of the fight.

As the situation remains uncertain and fluid, Manulife Singapore remains watchful on the evolving situation to ensure that its customers are supported in this time of difficulty.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the reproduced articles,

please email: Julia.Zhang@ubmsinoexpo.com to motify or remove the content.